Marietta, Pa. – Malaria. Tuberculosis. Alzheimer’s disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler’s diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it. Many could be on the market in five years or less. Contrast that with five years ago, when so many companies had abandoned the vaccine business that half the U.S. supply of flu shots was lost because of factory contamination at one of the two manufacturers left. Vaccines are no longer a sleepy, low-profit niche in a booming drug industry. Today, they’re starting to give ailing pharmaceutical makers a shot in the arm. The lure of big profits, advances in technology and growing government support has been drawing in new companies, from nascent biotechs to Johnson & Johnson. That means recent remarkable strides in overcoming dreaded diseases and annoying afflictions likely will continue. “Even if a small portion of everything that’s going on now is successful in the next 10 years, you put that together with the last 10 years (and) it’s going to be characterized as a golden era,” says Emilio Emini, Pfizer Inc.’s head of vaccine research. Vaccines now are viewed as a crucial path… Read full this story
- Profit on the cards: Card Factory sees profits rise despite fall in like-for-like sales
- Cake maker Finsbury Foods sees profits slip after bakery closure
- Spirit in the sky: City Pub Group sees profits jump after bumper World Cup summer
- Federal funding on the way to aide public health on Guam
- Friends take on the West Highland Way in aid of Kilbryde Hospice and Celtic FC Foundation.
- Increasing rental income sees profits at Ireland's biggest private landlord more than double
- Drug industry reacts to Oxfam's allegations of tax-dodging
- Balfour Beatty sees profits soar
- Investment pays off as Churchill China sees profits jump by 24%
- Sunderland outdoor specialist Berghaus sees profits rise for second year
Shots on the way for Alzheimer's, AIDS, herpes and more as drug industry sees profit in vaccines have 325 words, post on www.nydailynews.com at November 18, 2009. This is cached page on Goose Art. If you want remove this page, please contact us.